HUTCHMED (China) (HMDCF) EBITDA (2015 - 2021)

HUTCHMED (China) (HMDCF) has 6 years of EBITDA data on file, last reported at -$252.5 million in Q4 2021.

• EBITDA for Q4 2021 came in at -$252.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $349.7 million (changed N/A YoY), and the FY2025 annual result was $102.8 million, up 335.3% from the prior year.
• EBITDA eased to -$252.5 million in Q4 2021 per HMDCF's latest filing, from $219.9 million in the prior quarter.
• Over five years, EBITDA peaked at $220.6 million in Q1 2021 and troughed at -$252.5 million in Q4 2021.
• A 4-year average of $28.2 million and a median of $36.0 million in 2019 frame the typical range for EBITDA.
• The sharpest annual moves came in 2019 and 2020: EBITDA sank 343.04% in 2019, then soared 269.04% in 2020.
• A 4-year view of EBITDA shows it stood at -$161.1 million in 2018, then surged by 152.55% to $84.7 million in 2019, then surged by 90.93% to $161.7 million in 2020, then sank by 256.16% to -$252.5 million in 2021.
• Business Quant data shows HMDCF's EBITDA at -$252.5 million in Q4 2021, $219.9 million in Q2 2021, and $220.6 million in Q1 2021.